All In Biotech

Drug Trial Radar · NCT05489705

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Deliver Insights in Hypertrophic Cardiomyopathy and Observational Outcomes in Real World: United States and European Prospective Registry Study

Last checked: Nov 20, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

1,700

Planned (sponsor's estimate)

Start

Aug 16, 2022

Primary completion

Aug 17, 2029

Study completion Aug 17, 2029

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Aug 5, 2022

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This registry evaluates patient characteristics, real-world treatment patterns, and short- and long-term outcomes in a population of patients in the United States and Europe with symptomatic obstructive hypertrophic cardiomyopathy (HCM) who are receiving mavacamten, receiving other treatment for obstructive HCM, or not receiving treatment for obstructive HCM due to intolerance or failure of prior treatment. United States Sub-Study: The purpose of this study is to evaluate the safety of mavacamten in patients with symptomatic obstructive HCM in the real-world setting. Europe Sub-Study: The purpose of this study is to evaluate the effectiveness and safety of mavacamten in patients with symptomatic obstructive HCM in the real-world setting.

Conditions

  • Obstructive Hypertrophic Cardiomyopathy

Interventions

  • MavacamtenDrug

    As per product label

  • Non-mavacamten symptomatic oHCM therapyDrug

    Including Beta-blocker (BB), non-dihydropyridine (non-DHP) calcium channel blocker (CCB) and/or disopyramide as per product label

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence rate of new or worsening heart failure due to systolic dysfunction among participants with symptomatic obstructive HCM during periods of exposure to mavacamten and other oHCM treatmentTime frame: Up to 5 Years
  2. Change in resting left ventricular outflow tract (LVOT) gradient from baselineTime frame: Up to 18 months

Locations

101 sites in 9 countries. Site status is shown where the registry gives one.

  • Alaska Heart Institute

    Anchorage, Alaska · Recruiting

  • Pima Heart and Vascular

    Tucson, Arizona · Recruiting

  • UAMS

    Little Rock, Arkansas · Recruiting

  • Local Institution - 0037

    La Jolla, California · Active not recruiting

  • Keck School of Medicine of USC-Usc

    Los Angeles, California · Recruiting

  • Stanford Health Care Hospital & Clinics

    Palo Alto, California · Recruiting

  • University Of California San Francisco Medical Center

    San Francisco, California · Recruiting

  • UC Denver, AMC

    Aurora, Colorado · Recruiting

  • Local Institution - 0067

    Hartford, Connecticut · Active not recruiting

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia · Recruiting

  • Local Institution - 0065

    Jacksonville, Florida · Active not recruiting

  • Local Institution - 0046

    Honolulu, Hawaii · Active not recruiting

  • University of Chicago Dept of Medicine

    Chicago, Illinois · Recruiting

  • Indiana. University

    Indianapolis, Indiana · Recruiting

  • Franciscan Physician Network-Indiana Heart Physicians

    Indianapolis, Indiana · Recruiting

  • Local Institution - 0045

    Iowa City, Iowa · Active not recruiting

  • Local Institution - 0059

    Baltimore, Maryland · Active not recruiting

  • MedStar Health Research Institute

    Baltimore, Maryland · Recruiting

  • Harvard (Massachusetts General Hospital)

    Boston, Massachusetts · Recruiting

  • Harvard Medical School - Brigham and Women's Hospital (BWH)

    Boston, Massachusetts · Recruiting

  • Spectrum Health Medical Group

    Grand Rapids, Michigan · Recruiting

  • Henry Ford Health System

    West Bloomfield, Michigan · Recruiting

  • Minneapolis Heart Institute Foundation

    Minneapolis, Minnesota · Recruiting

  • Cardiology Associates Research, Llc

    Tupelo, Mississippi · Recruiting

  • St. Luke's Mid-America Heart Institute

    Kansas City, Missouri · Recruiting

  • Local Institution - 0033

    Kansas City, Missouri · Active not recruiting

  • Washington University

    St Louis, Missouri · Recruiting

  • CHI Health Reseach Center

    Omaha, Nebraska · Recruiting

  • Hackensack University Medical Center

    Hackensack, New Jersey · Recruiting

  • Local Institution - 0026

    Morristown, New Jersey · Active not recruiting

  • Bassett Medical Center

    Cooperstown, New York · Recruiting

  • Local Institution - 0009

    New York, New York · Active not recruiting

  • Mount Sinai Hospital

    New York, New York · Recruiting

  • Saint Francis Hospital

    Roslyn, New York · Recruiting

  • WMCHealth Advanced Physician Services

    Valhalla, New York · Recruiting

  • Focus Clinical Research

    Charlotte, North Carolina · Recruiting

  • Duke University Health System

    Durham, North Carolina · Recruiting

  • Christ Hospital Health Network

    Cincinnati, Ohio · Recruiting

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio · Recruiting

  • Local Institution - 0003

    Cleveland, Ohio · Active not recruiting

Showing 40 of 101 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.